Ultragenyx appoints general counsel

By 2016-06-21T11:00:00

Ultragenyx Pharmaceutical, a clinical-stage biopharmaceutical company, has appointed Karah Parschauer as general counsel. In this newly created role, she will be responsible for leading the company's legal, compliance, and corporate governance functions.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.